Biosimilars are not replicas in the conventional sense; they are scientifically reconstructed therapeutic options grounded in rigorous comparative evidence. Their purpose is not to mimic for mimicry’s sake, but to deliver clinically equivalent outcomes at lower cost, widening patient access to life-changing biologics. Unlike small-molecule generics—which must be chemically identical to the originator—biosimilars are held to … Dive into the Art of “Highly Similar” of Biosimilars Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.